Taiwania Capital Management Corporation

Syncell is a proteomics technology company focused on enabling targeted protein drug discovery related to specific diseases. The company's innovative Microscoop™ technology allows for microscopy-guided nanoscale protein "scooping," facilitating unbiased subcellular spatial proteomic discovery. This advancement makes it possible to address complex biological problems and identify novel disease biomarkers and druggable targets. Syncell's system transforms a high-content microscope into a precision photolabeling machine, aiding researchers in high-content de novo spatial proteomics to efficiently harvest proteins from selected subcellular locations. Through its technology, Syncell aims to significantly enhance the understanding of diseases and the development of targeted therapies.

Litilit specializes in the development of ultra-short pulse lasers, offering advanced technology designed to meet the needs of the industrial laser market. Utilizing a patented laser pulse generator, Litilit achieves telecom-grade performance characterized by high reliability and scalability at competitive prices. The company's innovative femtosecond and self-starting laser technologies have proven to be effective across various industries, including medical equipment, bioimaging, consumer electronics, advanced manufacturing, 3D printing, and laser surgery. By leveraging its in-house expertise, Litilit provides tailored engineering solutions that deliver significant value to clients. This strategic approach positions the company as a leader in the next generation of laser technology, addressing the evolving demands of diverse sectors.